Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abdominal Obesity as a Therapeutic Target: Long-term Benefits of Abdominal Fat Loss and Weight Stabilization in High-risk Abdominally Obese Dyslipidemic Patients With the Features of the Metabolic Syndrome (SYNERGIE Study)

NCT06158191 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT06158191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06158191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abdominal Obesity as a Therapeutic Target: Long-term Benefits of Abdominal Fat Loss and Weight Stabilization in High-risk Abdominally Obese Dyslipidemic Patients With the Features of the Metabolic Syndrome (SYNERGIE Study)
Lead sponsor
Laval University
Phase
Not applicable
Overall status
Completed
Start date
March 26, 2004
Completion date
December 15, 2008
Enrollment
186 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiometabolic syndrome, diet, healthy, lifestyle-related condition, obesity, visceral